IL7R and irritable bowel syndrome: Recombinant strain of S. gordonii produces bioactive human interleukin 1 receptor antagonist (IL-1ra) through RVFP/IL-RA in vitro and could be suitable for selective targeting of the mucosal surface as a delivery system for inflammatory diseases such as IBD.